Neurotech start-up Paradromics raises $20M to address brain-related disorders via next-gen brain-computer interfaces

By SharpBrains | August 11, 2021 |

Neu­ralink Com­peti­tor Rais­es $20 Mil­lion for Brain Implants (Bloomberg): A com­peti­tor to Elon Musk’s Neu­ralink said it raised $20 mil­lion, enough to get it on track to intro­duce a new gen­er­a­tion of pow­er­ful and tiny elec­trodes to the human brain. Paradromics Inc., found­ed in 2015 about a year ahead of Neu­ralink, is build­ing brain-com­put­er inter­faces that…

Read More

Fast Forward to 2040: How to prepare for the new era in brain enhancement that will change the way we think, work, and heal

By Tan Le | March 19, 2020

Decades from now when our aug­ment­ed brains have enhanced our cog­ni­tive func­tion and trans­formed near­ly every aspect of our lives, many of us will look back and won­der why we didn’t do more to pre­pare for these inevitable changes. Gov­ern­ment lead­ers may grap­ple with the run­away effects of AI and brain enhance­ment on geopol­i­tics. Companies…

Read More

Mindstrong Health recruits slew of Silicon Valley talent

By SharpBrains | December 12, 2019

_______ Mind­strong Health Expands Exec­u­tive Team to Advance Tech­nol­o­gy for New Vir­tu­al Men­tal Health Care Mod­el (press release): “Mind­strong Health, a health­care inno­va­tion com­pa­ny ded­i­cat­ed to trans­form­ing men­tal health through inno­va­tions in dig­i­tal mea­sure­ment and vir­tu­al care mod­els, today announced the addi­tion of ten senior exec­u­tives to its lead­er­ship team includ­ing CEO Daniel Graf, who…

Read More

Apple/ Eli Lilly’s bet: Wearable and mobile consumer devices may well help us detect cognitive impairment and dementia

By SharpBrains | September 16, 2019

__________ Apple, Eli Lil­ly research whether devices can detect demen­tia signs (Health­care Dive): “Demen­tia, which affects rough­ly 47 mil­lion peo­ple across the globe, costs $1 tril­lion world­wide, accord­ing to the World Health Orga­ni­za­tion. Ear­ly test­ing for the con­di­tion is spo­radic and, when con­duct­ed, it’s often not sen­si­tive enough to detect ear­ly stages of men­tal decline, creating…

Read More

Update: 200 common prescription medications increase depression risk

By SharpBrains | June 28, 2018

___ Dear read­er, Time for Sharp­Brains e‑newsletter. It’s been a busy month, once again bring­ing to the fore­front the lim­i­ta­tions of our cur­rent health­care sys­tem and, on the pos­i­tive side, the grow­ing oppor­tu­ni­ties to improve Brain Health and Men­tal Health for all, if we pay atten­tion to (and act on) lat­est research, think­ing and tools. New…

Read More